Growth Metrics

Gyre Therapeutics (GYRE) Assets Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 105.20%
Dec 31, 2025 25.15%
Sep 30, 2025 72.56%
Jun 30, 2025 22.34%
Mar 31, 2025 47.71%
Dec 31, 2024 31.10%
Sep 30, 2024 16.83%
Jun 30, 2024 5.91%
Mar 31, 2024 0.81%
Dec 31, 2023 7.11%
Sep 30, 2023 -55.33%
Jun 30, 2023 -53.55%
Mar 31, 2023 -44.65%
Dec 31, 2022 -4.90%
Sep 30, 2022 -30.35%
Jun 30, 2022 -6.15%
Mar 31, 2022 -28.86%
Dec 31, 2021 -23.62%
Sep 30, 2021 -16.19%
Jun 30, 2021 -9.98%
Mar 31, 2021 -6.54%
Dec 31, 2020 33.89%
Sep 30, 2020 48.14%
Jun 30, 2020 46.14%
Mar 31, 2020 56.11%
Dec 31, 2019 37.28%
Sep 30, 2019 21.15%
Jun 30, 2019 20.80%
Mar 31, 2019 22.04%
Dec 31, 2018 21.57%
Sep 30, 2018 21.43%
Jun 30, 2018 11.31%
Mar 31, 2018 10.84%
Dec 31, 2017 136.66%
Sep 30, 2017 -33.34%
Jun 30, 2017 -31.72%
Mar 31, 2017 -39.94%
Dec 31, 2016 -36.08%
Sep 30, 2016 -31.11%
Jun 30, 2016 -30.09%
Mar 31, 2016 -29.91%
Dec 31, 2015 -28.42%
Sep 30, 2015 -28.46%
Jun 30, 2015 -21.93%
Mar 31, 2015 -22.61%
Dec 31, 2014 -77.40%
Sep 30, 2014 -25.40%
Jun 30, 2014 -25.41%
Dec 31, 2013 -17.82%